Literature DB >> 2308604

Uremia and host defenses.

N E Tolkoff-Rubin, R H Rubin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2308604     DOI： 10.1056/NEJM199003153221109

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Physicochemical characterization of a polypeptide present in uremic serum that inhibits the biological activity of polymorphonuclear cells.

Authors:  W H Hörl; M Haag-Weber; A Georgopoulos; L H Block
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

2.  In vitro effect of cefodizime, imipenem/cilastatin and co-trimoxazole on dexamethasone and cyclosporin A depressed phagocytosis.

Authors:  A Dhondt; R Vanholder; M A Waterloos; G Glorieux; R De Smet; S Ringoir
Journal:  Infection       Date:  1998 Mar-Apr       Impact factor: 3.553

3.  Soluble CD40 in the serum of healthy donors, patients with chronic renal failure, haemodialysis and chronic ambulatory peritoneal dialysis (CAPD) patients.

Authors:  R F Schwabe; H Engelmann; S Hess; H Fricke
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

Review 4.  Immunization in children with chronic renal failure: a practical approach.

Authors:  Thomas J Neuhaus
Journal:  Pediatr Nephrol       Date:  2004-12       Impact factor: 3.714

5.  Hepatitis C infection in children and adolescents on haemodialysis and after renal transplant.

Authors:  M Greco; K Cristiano; G Leozappa; M Rapicetta; G Rizzoni
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

6.  Dynamic observations on NK cell activity and IL-2 and IFN gamma production in vitro in patients on maintenance hemodialysis.

Authors:  Y Dai; Y Yu; S C Tang; T Y Cai; D Li
Journal:  J Tongji Med Univ       Date:  1993

7.  A boy undergoing maintenance hemodialysis who developed mediastinal lymph node tuberculosis.

Authors:  Mitsuru Okada; Keisuke Sugimoto; Kazuro Yagi; Hidehiko Yanagida; Nobutada Tabata; Tsukasa Takemura
Journal:  Clin Exp Nephrol       Date:  2006-06       Impact factor: 2.617
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.